What Is The Hep C Virus Causes Spread Treatment?

Hepatitis C is a liver infection caused by the hepatitis C virus (HCV). It spreads through blood-to-blood contact, most commonly through shared needles or other drug-injection equipment. Modern treatments can cure most people with hepatitis C in about 8 to 12 weeks, but many people do not know they have it because symptoms often do not appear for years.

What Exactly Is the Hepatitis C Virus?

Hepatitis C is one of several viruses that attack the liver. The name “hepatitis” means inflammation of the liver. The C virus is a single-stranded RNA virus that specifically infects liver cells called hepatocytes.

The virus has a remarkable ability to evade the immune system. It mutates rapidly, which makes it difficult for the body to clear on its own. About 15% to 25% of people who get infected will clear the virus without treatment within six months. The rest develop a chronic infection that lasts for decades if untreated.

There are several genotypes, or strains, of hepatitis C. Genotype 1 is the most common in the United States. Genotypes matter mainly because they guide treatment choices, though modern medications work well against all of them.

How Does Hepatitis C Spread?

Hepatitis C spreads only through blood. The virus does not spread through casual contact, coughing, sneezing, hugging, sharing food, or breastfeeding. It is not transmitted through sexual contact in most cases, though the risk is not zero.

The main ways people get hepatitis C today include:

• Sharing needles, syringes, or other equipment to inject drugs
• Receiving a blood transfusion or organ transplant before 1992, when blood screening became widely available
• Needlestick injuries in healthcare settings
• Being born to a mother with hepatitis C
• Sharing personal items like razors or toothbrushes that may have trace amounts of blood

Injection drug use is now the leading cause of new infections in the United States. The opioid crisis has driven a significant increase in hepatitis C cases among younger adults. Some research suggests that even sharing straws or dollar bills to snort drugs could transmit the virus if blood is present, though this is less common.

Sexual transmission does occur but is uncommon in monogamous heterosexual couples. The risk increases among men who have sex with men, particularly those with HIV or those engaging in rough sexual practices that cause bleeding.

What Are the Symptoms of Hepatitis C?

Most people with acute hepatitis C have no symptoms at all. When symptoms do appear, they typically show up 2 to 12 weeks after exposure and may include fatigue, fever, nausea, poor appetite, muscle aches, and jaundice — a yellowing of the skin and eyes.

The bigger problem is chronic infection. About 70% to 85% of people who do not clear the virus develop chronic hepatitis C. Many live with it for decades without knowing. The liver slowly accumulates damage over time.

When symptoms of chronic hepatitis C finally appear, they often signal advanced liver disease. These include persistent fatigue, abdominal swelling, leg swelling, easy bruising, confusion, and jaundice. By this point, significant liver scarring, called cirrhosis, has often already developed.

The CDC recommends one-time hepatitis C testing for all adults. It also recommends testing for pregnant women during each pregnancy. This universal screening approach exists because the infection is so often silent.

How Is Hepatitis C Diagnosed?

Diagnosis starts with a blood test called the HCV antibody test. This test looks for antibodies your immune system produced in response to the virus. A positive result means you were exposed to the virus at some point. It does not distinguish between a past infection that cleared and a current active infection.

If the antibody test is positive, the next step is an HCV RNA test. This test detects the actual virus in the blood. A positive RNA test confirms an active infection. A negative RNA test with a positive antibody test means you cleared the infection on your own.

If active infection is confirmed, doctors typically order additional tests. These include a viral load measurement and genotype testing. They may also assess liver health through blood tests that measure liver enzymes and through imaging studies or a test called FibroScan that measures liver stiffness.

What Is the Treatment for Hepatitis C?

Treatment for hepatitis C has transformed dramatically in the last decade. The old interferon-based treatments were long, difficult, and often unsuccessful. They required weekly injections and caused severe flu-like side effects for up to a year.

Modern treatment uses direct-acting antiviral medications, or DAAs. These are oral pills taken once daily. They work by blocking specific proteins the virus needs to replicate. Typical treatment lasts 8 to 12 weeks, and cure rates exceed 95% for most people.

Cure is defined as an undetectable viral load 12 weeks after completing treatment. This is called a sustained virologic response, or SVR. Once you achieve SVR, the virus is considered eliminated from your body. You are not immune to future infection, but the existing infection is gone.

The specific medication regimen depends on your genotype, whether you have cirrhosis, and whether you have been treated before. Common medications include glecaprevir-pibrentasvir and sofosbuvir-velpatasvir. These are typically well tolerated with minimal side effects.

Treatment is recommended for nearly everyone with chronic hepatitis C. The exception is people with very limited life expectancy from other conditions, where treatment may not provide meaningful benefit. Your doctor will help determine the right approach for your situation.

What Happens If Hepatitis C Goes Untreated?

Untreated chronic hepatitis C leads to progressive liver damage over 20 to 30 years. About 15% to 30% of people with chronic infection develop cirrhosis within two decades. Once cirrhosis develops, complications can include liver failure and liver cancer.

Hepatitis C is a leading cause of hepatocellular carcinoma, the most common type of primary liver cancer. The risk of liver cancer increases once cirrhosis is present. People with cirrhosis from hepatitis C should undergo regular ultrasound screenings every six months to check for tumors.

Treating hepatitis C before cirrhosis develops essentially eliminates the excess risk of liver cancer and liver failure. Even people with compensated cirrhosis benefit greatly from treatment, though their liver cancer risk does not return to zero.

Hepatitis C also affects health beyond the liver. Chronic infection is associated with insulin resistance, type 2 diabetes, kidney disease, and certain types of lymphoma. Treating the virus appears to reduce some of these risks, though the evidence is stronger for liver outcomes than for these other conditions.

Can Hepatitis C Be Prevented?

There is no vaccine for hepatitis C. This is different from hepatitis A and hepatitis B, which both have effective vaccines. The virus’s rapid mutation makes vaccine development challenging, though research continues.

Prevention focuses on avoiding blood exposure. This means never sharing needles, syringes, or other injection equipment. It also means not sharing razors, toothbrushes, or nail clippers with others. Healthcare workers should follow standard precautions with needles and sharps.

For people who inject drugs, accessing sterile equipment through syringe service programs significantly reduces transmission risk. These programs are evidence-based and have been shown to reduce hepatitis C and HIV transmission without increasing drug use.

If you have hepatitis C, you can protect others by covering any open wounds, not donating blood or organs, and cleaning up blood spills with a bleach solution. Sex partners do not need to be concerned in most cases, though using condoms reduces the already low risk of sexual transmission.

What Is the Outlook for People With Hepatitis C?

The outlook for people with hepatitis C is excellent in 2024. Most people can be cured with a short course of oral medication. The World Health Organization has set a goal to eliminate hepatitis C as a public health threat by 2030.

Barriers to elimination remain. Many people do not know they are infected because they have no symptoms. Some people face high medication costs, though generic versions have reduced prices significantly. Others face stigma or lack access to healthcare.

If you have risk factors for hepatitis C, get tested. If you test positive, seek treatment. The medications work, they are generally well tolerated, and they can prevent decades of liver damage. This is one of the few chronic viral infections that medicine can now reliably cure.